C16 Biosciences, Inc. — Form D/A
C16 Biosciences, Inc. of New York, NY, a company, filed a Form D amendment with the SEC on 2020-03-11. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-11
- Form: D/A
- Accession: 0001757728-20-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 45
- Date of first sale: 2020-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361783
Issuer
- Name: C16 Biosciences, Inc.
- CIK: 0001757728
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 619 W 54th Street, 7th Floor, New York, NY, 10019
- Phone: 917-983-6004
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David Heller | Promoter | NEW YORK, NY |
| Harold McNamara | Promoter | New York, NY |
| David Heller | Director | NEW YORK, NY |
| Peter Turner | Director | Vancouver, A1 |
| Harold McNamara | Director | New York, NY |
| Shara Ticku | Director | New York, NY |
| Shara Ticku | Executive Officer | New York, NY |
| Shara Ticku | Promoter | New York, NY |
| Andrew Shumaker | Director | Somerville, MA |
| Andrew Shumaker | Promoter | Somerville, MA |
Other filings by this issuer (3)
More